The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells

PURPOSE: Glioblastoma multiforme (GBM) is resistant to current cytotoxic therapies, in part because of enhanced DNA repair. Activation of the receptor tyrosine kinase c-Met has been shown to protect cancer cells from DNA damage. We hypothesized that inhibiting c-Met would decrease this protection an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Welsh, James W, Mahadevan, Daruka, Ellsworth, Ron, Cooke, Laurence, Bearss, David, Stea, Baldassarre
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2009
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806296/
https://ncbi.nlm.nih.gov/pubmed/20028557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-4-69
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars